DK624287A - Komprimeret tablet eller kapsel - Google Patents

Komprimeret tablet eller kapsel

Info

Publication number
DK624287A
DK624287A DK624287A DK624287A DK624287A DK 624287 A DK624287 A DK 624287A DK 624287 A DK624287 A DK 624287A DK 624287 A DK624287 A DK 624287A DK 624287 A DK624287 A DK 624287A
Authority
DK
Denmark
Prior art keywords
capsule
pharmacologically active
compressed table
micronized
hydrophobic
Prior art date
Application number
DK624287A
Other languages
English (en)
Other versions
DK167341B1 (da
DK624287D0 (da
Inventor
Coenraad F Lerk
Gerad Klaas Bolhuis
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DK624287A publication Critical patent/DK624287A/da
Publication of DK624287D0 publication Critical patent/DK624287D0/da
Application granted granted Critical
Publication of DK167341B1 publication Critical patent/DK167341B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK624287A 1986-04-01 1987-11-27 Komprimeret tablet eller kapsel indeholdende methylprednisolon DK167341B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US84662086A 1986-04-01 1986-04-01
US84662086 1986-04-01
US8700302 1987-02-17
PCT/US1987/000302 WO1987005804A1 (en) 1986-04-01 1987-02-17 Methylprednisolone/sodium carboxymethyl starch tablet composition

Publications (3)

Publication Number Publication Date
DK624287A true DK624287A (da) 1987-11-27
DK624287D0 DK624287D0 (da) 1987-11-27
DK167341B1 DK167341B1 (da) 1993-10-18

Family

ID=25298443

Family Applications (1)

Application Number Title Priority Date Filing Date
DK624287A DK167341B1 (da) 1986-04-01 1987-11-27 Komprimeret tablet eller kapsel indeholdende methylprednisolon

Country Status (8)

Country Link
EP (1) EP0301006B1 (da)
JP (1) JPH01501934A (da)
KR (1) KR880701098A (da)
AU (1) AU7084587A (da)
DK (1) DK167341B1 (da)
HK (1) HK58497A (da)
NO (1) NO175884C (da)
WO (1) WO1987005804A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
SK282072B6 (sk) * 1991-01-30 2001-10-08 The Wellcome Foundation Limited Tableta s obsahom lamotrigínu dispergovateľná vo vode a spôsob jej prípravy
ES2160582T3 (es) * 1992-04-03 2001-11-16 Nippon Kayaku Kk Capsula dura de ocfosfato de citarabina.
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
GB2292079B (en) * 1994-08-12 1998-07-15 Flexpharm Ltd Coated prednisolone preparation for the treatment of inflamatory bowel disease
SE504902C2 (sv) * 1994-11-02 1997-05-26 Diabact Ab Beredning för påvisande av Helicobacter pylori i magsäcken
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
UA72207C2 (uk) 1998-04-07 2005-02-15 Брістол- Майєрс Сквібб Фарма Компані Фармацевтична композиція ефавіренцу з добавкою дезінтегруючих агентів у вигляді швидкорозчинних капсул або таблеток та спосіб її виготовлення
US6599530B2 (en) * 1998-09-14 2003-07-29 Orion Corporation Oral compacted composition comprising catechol derivatives
DE19855203A1 (de) * 1998-11-30 2000-05-31 Kurt Heinz Bauer Coprozessiertes Polysaccharidprodukt
DE19922537A1 (de) * 1999-05-10 2000-11-16 Roland Bodmeier Darreichungsform zur Applikation in Körperöffnungen
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
IL156445A0 (en) 2001-01-26 2004-01-04 Schering Corp Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
KR100882156B1 (ko) * 2003-08-08 2009-02-06 아지노모토 가부시키가이샤 나테글리니드 함유 제제
EP1744760B1 (en) 2004-04-22 2015-01-07 AcuCort AB Pharmaceutical compositions for acute glucocorticoid therapy
PL1916995T5 (pl) 2005-07-29 2022-10-31 Stichting Groningen Centre For Drug Research Kontrolowany wartością ph impulsowy układ podawczy, sposoby przygotowania i zastosowanie
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
JP6037687B2 (ja) * 2011-07-08 2016-12-07 サノフィ株式会社 グリメピリドを含有する口腔内崩壊錠
BE1021446B1 (nl) * 2015-01-06 2015-11-24 Stasisport Pharma Nv Methylprednisolon tablet en werkwijze
CN106265568B (zh) * 2016-08-30 2018-08-10 林州中农颖泰生物肽有限公司 一种水溶性醋酸地塞米松片及其制备方法
CN109925288A (zh) * 2017-12-18 2019-06-25 江苏开元药业有限公司 一种糖皮质激素药物片剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2200778B2 (de) * 1971-01-13 1974-04-18 Sandoz Ag, Basel (Schweiz) Verwendung von hochmolekularem, unlöslichem, quervernetztem Polyvinylpyrrolidon als Sprengmittel in festen Arzneiformen
ATE13486T1 (de) * 1980-11-12 1985-06-15 Ciba Geigy Ag Schnellzerfallende arzneimittel-presslinge.
GB8403360D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions

Also Published As

Publication number Publication date
EP0301006A1 (en) 1989-02-01
NO175884B (no) 1994-09-19
DK167341B1 (da) 1993-10-18
JPH01501934A (ja) 1989-07-06
HK58497A (en) 1997-05-09
AU7084587A (en) 1987-10-20
KR880701098A (ko) 1988-07-25
NO175884C (no) 1994-12-28
WO1987005804A1 (en) 1987-10-08
DK624287D0 (da) 1987-11-27
NO874989L (no) 1987-11-30
EP0301006B1 (en) 1992-05-06
NO874989D0 (no) 1987-11-30

Similar Documents

Publication Publication Date Title
DK624287A (da) Komprimeret tablet eller kapsel
GR3004448T3 (da)
GB8603523D0 (en) Slow release formulation
DE3271829D1 (en) An allergen dry powder composition and process for its preparation
NO169155C (no) Fremgangsmaate for fremstilling av ibuprofenholdige kapsler av myk gelatin
PH23698A (en) Sustained release compositions comprising hydroxypropyl cellulose ethers
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
MY101791A (en) New benzimidazole derivatives
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
PT76314B (en) Process for the preparation of biologically active polysaccharide concentrates and of pharmaceutical and cosmetic compositions containing them
EP0130550A3 (de) Auf Schleimhäute des Mundes, der Nase und/oder des Rachens wirkende Arzneimittel auf der Basis von Heparin und Tensiden
DK486189D0 (da) Psyllium-froeskaller og midler omfattende samme
SE8804628D0 (sv) New compounds
DE2966411D1 (en) Imidazolylvinylethers, their preparation and application as active agent in pharmaceutical and biocidal compositions
ES542430A0 (es) Un procedimiento para la preparacion de una composicion antiacida de alginato de magnesio.
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
DE59001005D1 (de) Hilfsmittelfreie riboflavingranulate.
SE8601457D0 (sv) Compositions of liposomes and b?712-receptor active substances for inhalation
ES2060293T3 (es) Nueva sustancia antiulcerosa.
ATE85213T1 (de) Einen wirkstoff und ein in wasser quellendes polymer enthaltendes arzneimittel.
ATE77555T1 (de) Guar-mehl.
IT8221801A0 (it) Derivati di 1, 2, 3,4-tetraidronaftalene, procedimentodi preparazione e relative composizioni farmaceutiche.
NZ219884A (en) Perhydrothiazepine and perhydroazepine derivatives and pharmaceutical compositions
DE3563416D1 (en) Hexetidin-containing therapeutically active agent, method for its preparation and its use as a vaginal disinfectant
SG25394G (en) Sustained release pharmaceutical compositions and the preparation of particles for use therein.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired